Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV-1 | 46 | 2013 | 6850 | 2.200 |
Why?
|
CD8-Positive T-Lymphocytes | 28 | 2013 | 4554 | 1.230 |
Why?
|
T-Lymphocytes, Cytotoxic | 15 | 2010 | 1765 | 1.040 |
Why?
|
HIV Long-Term Survivors | 8 | 2012 | 121 | 1.030 |
Why?
|
HIV Infections | 35 | 2013 | 17159 | 0.970 |
Why?
|
Histocompatibility Antigens Class I | 7 | 2012 | 1354 | 0.950 |
Why?
|
Receptors, Immunologic | 5 | 2011 | 1434 | 0.810 |
Why?
|
HLA-B Antigens | 5 | 2012 | 331 | 0.800 |
Why?
|
Dendritic Cells | 5 | 2012 | 2730 | 0.720 |
Why?
|
Genes, MHC Class I | 5 | 2010 | 240 | 0.680 |
Why?
|
Antigen Presentation | 6 | 2012 | 1254 | 0.650 |
Why?
|
Epitopes, T-Lymphocyte | 14 | 2012 | 825 | 0.650 |
Why?
|
Acquired Immunodeficiency Syndrome | 9 | 2009 | 2197 | 0.650 |
Why?
|
Telomere-Binding Proteins | 1 | 2012 | 119 | 0.380 |
Why?
|
Receptors, HIV | 1 | 2011 | 159 | 0.370 |
Why?
|
HLA Antigens | 3 | 2011 | 1369 | 0.350 |
Why?
|
HLA-A3 Antigen | 3 | 2006 | 34 | 0.340 |
Why?
|
Monocytes | 2 | 2010 | 2574 | 0.340 |
Why?
|
Viral Regulatory and Accessory Proteins | 3 | 2005 | 153 | 0.340 |
Why?
|
Gene Products, gag | 4 | 2006 | 312 | 0.330 |
Why?
|
CD4-Positive T-Lymphocytes | 7 | 2012 | 4355 | 0.330 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 698 | 0.320 |
Why?
|
Membrane Glycoproteins | 5 | 2012 | 3731 | 0.300 |
Why?
|
Immunodominant Epitopes | 5 | 2006 | 241 | 0.300 |
Why?
|
AIDS Vaccines | 4 | 2012 | 896 | 0.290 |
Why?
|
Antigens, CD | 5 | 2010 | 4002 | 0.290 |
Why?
|
Telomerase | 2 | 2010 | 747 | 0.280 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2006 | 71 | 0.270 |
Why?
|
HLA-B27 Antigen | 3 | 2012 | 63 | 0.260 |
Why?
|
Diseases in Twins | 1 | 2007 | 447 | 0.250 |
Why?
|
Receptors, Antigen, T-Cell | 4 | 2012 | 2536 | 0.250 |
Why?
|
Down-Regulation | 1 | 2012 | 2918 | 0.240 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2007 | 801 | 0.240 |
Why?
|
Leukocytes | 1 | 2011 | 2030 | 0.220 |
Why?
|
Immune Tolerance | 1 | 2012 | 2299 | 0.210 |
Why?
|
Myeloid Cells | 1 | 2007 | 821 | 0.210 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 4109 | 0.200 |
Why?
|
Nucleocapsid Proteins | 1 | 2002 | 76 | 0.200 |
Why?
|
Virus Replication | 9 | 2012 | 2431 | 0.180 |
Why?
|
Alleles | 5 | 2006 | 6900 | 0.180 |
Why?
|
HLA-A Antigens | 4 | 2006 | 225 | 0.180 |
Why?
|
HIV | 1 | 2007 | 1579 | 0.180 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 3076 | 0.160 |
Why?
|
Amino Acid Sequence | 12 | 2008 | 13456 | 0.150 |
Why?
|
Species Specificity | 3 | 2012 | 2413 | 0.140 |
Why?
|
Immunity, Cellular | 4 | 2011 | 1558 | 0.120 |
Why?
|
Epitopes | 5 | 2010 | 2506 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2008 | 1351 | 0.120 |
Why?
|
HIV Antigens | 3 | 2004 | 325 | 0.110 |
Why?
|
Molecular Sequence Data | 10 | 2007 | 17628 | 0.110 |
Why?
|
Up-Regulation | 3 | 2012 | 4127 | 0.110 |
Why?
|
HLA-A2 Antigen | 2 | 2005 | 211 | 0.110 |
Why?
|
Bystander Effect | 1 | 2013 | 90 | 0.100 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 3 | 2012 | 148 | 0.100 |
Why?
|
Amino Acid Substitution | 2 | 2006 | 1737 | 0.090 |
Why?
|
Humans | 48 | 2013 | 760261 | 0.090 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 358 | 0.090 |
Why?
|
Immunophenotyping | 2 | 2013 | 1870 | 0.080 |
Why?
|
Peptides | 3 | 2010 | 4358 | 0.080 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 3 | 2012 | 206 | 0.080 |
Why?
|
T-Lymphocytes | 2 | 2004 | 10183 | 0.080 |
Why?
|
Virus Integration | 1 | 2011 | 302 | 0.080 |
Why?
|
Gene Products, nef | 2 | 2006 | 100 | 0.080 |
Why?
|
Interleukin-12 | 1 | 2011 | 584 | 0.080 |
Why?
|
Cell Count | 1 | 2013 | 1838 | 0.080 |
Why?
|
Solubility | 1 | 2010 | 1088 | 0.080 |
Why?
|
Interferon-gamma | 7 | 2005 | 3160 | 0.080 |
Why?
|
Lymphocyte Activation | 2 | 2013 | 5498 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2011 | 4357 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 2 | 2013 | 1828 | 0.080 |
Why?
|
Viral Proteins | 3 | 2004 | 1802 | 0.070 |
Why?
|
Consensus Sequence | 2 | 2005 | 367 | 0.070 |
Why?
|
Viremia | 3 | 2007 | 708 | 0.070 |
Why?
|
Evolution, Molecular | 2 | 2007 | 1884 | 0.070 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2012 | 915 | 0.070 |
Why?
|
Cell Proliferation | 3 | 2013 | 10434 | 0.070 |
Why?
|
Disease Susceptibility | 1 | 2013 | 1791 | 0.070 |
Why?
|
Killer Cells, Natural | 2 | 2005 | 2204 | 0.060 |
Why?
|
Twins, Monozygotic | 1 | 2007 | 469 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2012 | 9388 | 0.060 |
Why?
|
Disease Progression | 5 | 2012 | 13505 | 0.060 |
Why?
|
Capsid Proteins | 1 | 2008 | 467 | 0.060 |
Why?
|
Genes, nef | 1 | 2004 | 52 | 0.060 |
Why?
|
Adult | 14 | 2012 | 219847 | 0.060 |
Why?
|
Blotting, Western | 1 | 2012 | 5039 | 0.060 |
Why?
|
Lymphocyte Subsets | 1 | 2005 | 310 | 0.060 |
Why?
|
Cross Reactions | 1 | 2006 | 818 | 0.060 |
Why?
|
Middle Aged | 13 | 2012 | 220175 | 0.060 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2012 | 1894 | 0.060 |
Why?
|
Gene Silencing | 1 | 2010 | 1511 | 0.060 |
Why?
|
CD4 Lymphocyte Count | 4 | 2012 | 2569 | 0.060 |
Why?
|
Mutation | 7 | 2010 | 29950 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2008 | 1135 | 0.050 |
Why?
|
HLA-B7 Antigen | 1 | 2002 | 50 | 0.050 |
Why?
|
Cell Survival | 1 | 2013 | 5796 | 0.050 |
Why?
|
Acute Disease | 5 | 2005 | 7268 | 0.050 |
Why?
|
Superinfection | 1 | 2002 | 64 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2012 | 22041 | 0.050 |
Why?
|
Telomere | 1 | 2008 | 934 | 0.050 |
Why?
|
Ligands | 1 | 2008 | 3277 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3443 | 0.050 |
Why?
|
Epitope Mapping | 1 | 2002 | 297 | 0.050 |
Why?
|
Male | 18 | 2012 | 359413 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2013 | 3046 | 0.050 |
Why?
|
Cell Line | 3 | 2008 | 15626 | 0.040 |
Why?
|
Antigens, Viral | 1 | 2004 | 980 | 0.040 |
Why?
|
Drug Design | 1 | 2005 | 1062 | 0.040 |
Why?
|
Female | 17 | 2012 | 391011 | 0.040 |
Why?
|
Genome, Viral | 1 | 2003 | 658 | 0.040 |
Why?
|
China | 1 | 2004 | 2340 | 0.040 |
Why?
|
Viral Load | 4 | 2010 | 3323 | 0.040 |
Why?
|
Cytokines | 2 | 2010 | 7345 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3804 | 0.030 |
Why?
|
Anti-HIV Agents | 1 | 2012 | 4492 | 0.030 |
Why?
|
Young Adult | 3 | 2012 | 58673 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4900 | 0.030 |
Why?
|
HIV Core Protein p24 | 2 | 2005 | 245 | 0.030 |
Why?
|
Cells, Cultured | 4 | 2012 | 18968 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9196 | 0.030 |
Why?
|
Flow Cytometry | 3 | 2012 | 5873 | 0.030 |
Why?
|
Peptide Fragments | 2 | 2003 | 5120 | 0.030 |
Why?
|
Apoptosis | 1 | 2008 | 9497 | 0.030 |
Why?
|
Perforin | 1 | 2012 | 167 | 0.020 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 119 | 0.020 |
Why?
|
Vaccines, Subunit | 1 | 2012 | 161 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2011 | 67 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2002 | 3491 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 2012 | 630 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 25928 | 0.020 |
Why?
|
Base Sequence | 2 | 2011 | 12447 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2819 | 0.020 |
Why?
|
Antigenic Variation | 1 | 2006 | 118 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 1041 | 0.020 |
Why?
|
Cell Degranulation | 1 | 2007 | 278 | 0.020 |
Why?
|
Gene Products, vpr | 1 | 2005 | 33 | 0.020 |
Why?
|
vpr Gene Products, Human Immunodeficiency Virus | 1 | 2005 | 36 | 0.020 |
Why?
|
Lysosomal-Associated Membrane Protein 1 | 1 | 2004 | 25 | 0.020 |
Why?
|
Cohort Studies | 2 | 2006 | 41317 | 0.020 |
Why?
|
Viral Structural Proteins | 1 | 2004 | 95 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 2004 | 346 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2004 | 322 | 0.010 |
Why?
|
Genes, Viral | 1 | 2004 | 650 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2005 | 780 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2012 | 2415 | 0.010 |
Why?
|
RNA, Viral | 1 | 2011 | 2837 | 0.010 |
Why?
|
Human Immunodeficiency Virus Proteins | 1 | 2002 | 59 | 0.010 |
Why?
|
Caspase 3 | 1 | 2004 | 730 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2005 | 1168 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2004 | 929 | 0.010 |
Why?
|
Aged | 2 | 2012 | 168995 | 0.010 |
Why?
|
Caspases | 1 | 2004 | 878 | 0.010 |
Why?
|
Neutralization Tests | 1 | 2002 | 729 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2004 | 1792 | 0.010 |
Why?
|
Selection, Genetic | 1 | 2004 | 872 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 2755 | 0.010 |
Why?
|
Chronic Disease | 2 | 2005 | 9283 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2007 | 1811 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2004 | 1890 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2012 | 12412 | 0.010 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2002 | 975 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2002 | 1439 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2011 | 12762 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2002 | 2363 | 0.010 |
Why?
|
Phylogeny | 1 | 2002 | 2775 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 11902 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2006 | 12532 | 0.010 |
Why?
|
Adolescent | 2 | 2012 | 87747 | 0.010 |
Why?
|
Genetic Variation | 1 | 2004 | 6540 | 0.010 |
Why?
|
Infant | 1 | 2005 | 36030 | 0.000 |
Why?
|
Child, Preschool | 1 | 2005 | 42034 | 0.000 |
Why?
|
Child | 1 | 2005 | 79758 | 0.000 |
Why?
|
Animals | 1 | 2005 | 167940 | 0.000 |
Why?
|
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_